NEW YORK (GenomeWeb News) – GNI, a drug-discovery firm based in Tokyo, has tapped Wako Pure Chemical to market its biopathway imaging and modeling software in Japan, GNI said last week.
Beginning in April, Wako will sell GNI’s Cell Illustrator software through its partner agencies in Japan.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.